Revitalose

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Revitalose

What is Revitalose? (Authoritative Overview)

Property Description
Active ingredient Sodium Ascorbate (Vitamin C salt form)
Form Oral solution in drinkable ampoules
Pharmacological class Vitamin C Supplement, Antiscorbutic Agent
Common use Addressing Vitamin C deficiency, supporting recovery from fatigue
Origin Semi-synthetic (chemically derived salt)

What is Revitalose and What Type of Medicine Is It?

Revitalose is defined as a pharmaceutical preparation categorized as an essential micronutrient and a vitamin supplement, belonging to the high-level pharmacological class of antiscorbutic agents. Its primary function is to deliver a necessary and bioavailable form of Vitamin C to the body to correct deficiency states. Unlike specific prescription drugs, this preparation is commonly positioned as an Over-The-Counter (OTC) product intended for nutritional support during temporary periods of need. The requirement for this supplement arises because humans must acquire Vitamin C externally.

Composition, Form, and Origin: Sodium Ascorbate and the Oral Solution

The active constituent in Revitalose is Sodium Ascorbate, which is a mineral salt derivative of L-Ascorbic Acid (C6H7NaO6), classifying it as a single-ingredient product (Monotherapy). A differentiating factor for Revitalose is its form: it is typically formulated as an oral solution in drinkable ampoules. This liquid presentation, as opposed to conventional tablets, is often preferred by individuals who have difficulty swallowing solids, offering an advantage in ease of consumption. The Sodium Ascorbate form itself is recognized in pharmacological literature for being a buffered and highly soluble salt of the vitamin.

How Does Revitalose Generally Support the Body?

Revitalose supports the body by fulfilling the critical biological roles of Vitamin C. The active component is essential as a cofactor in enzymatic reactions, a function clinically recognized for supporting various processes, including the synthesis of collagen, a protein vital for connective tissue integrity. Furthermore, Sodium Ascorbate provides powerful cellular antioxidant defense. This general function supports the body during periods of stress, such as convalescence and temporary asthenia, and is utilized to maintain resilience against the general fatigue associated with suboptimal micronutrient status.

What side effects are possible with Revitalose?

Possible side effects and safety information

The regulatory safety information for Sodium Ascorbate, the active ingredient in Revitalose, notes that adverse reactions are primarily linked to the ingestion of large or high doses and prolonged exposure, rather than categorized by standard frequency bands.

Officially Documented Adverse Reactions

Adverse effects listed in regulatory documents often relate to intake of 1 gram or more daily and affect the following system-organ classes:

  • Gastrointestinal Disorders: Effects documented with high doses include diarrhea, nausea, vomiting, abdominal cramps, and heartburn.
  • Renal and Urinary Disorders: High intake may lead to the formation of renal calcium oxalate calculi (kidney stones) and hyperoxaluria.
  • Nervous System Effects: Headache, fatigue, disturbed sleep, and insomnia are cited reactions.

Serious Risks and Safety Constraints

Certain serious adverse reactions and safety constraints are explicitly documented in official labeling:

Constraint / Risk Description
Serious Risks Oxalate nephropathy and the formation of kidney stones are serious risks associated with prolonged, high-dose use. Hemolysis (red blood cell breakdown) is a documented serious reaction in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
At-Risk Populations Safety constraints advise caution in patients with a history of hyperoxaluria or kidney stones, elderly patients, and pediatric patients under two years old due to potential kidney risk.
Interference Notes High intake may officially interfere with certain laboratory tests that rely on oxidation-reduction reactions, such as specific tests for glucose. The medicine may also potentially interfere with anticoagulant treatments.

Safety Profile Context

The official safety structure emphasizes that adverse reactions are a function of the dose size and duration of consumption, particularly highlighting the need for caution in populations with specific metabolic vulnerabilities. The profile is primarily focused on delineating these high-dose and susceptibility-related risks.

Overdose and Emergency Response

The regulatory overdose profile for Revitalose (Sodium Ascorbate) focuses strictly on acute physical manifestations and the risk of severe, life-altering complications, as defined in government labeling.

Documented Overdose Manifestations

Overdosage is officially documented to present with clear gastrointestinal disturbances. These symptoms include nausea, vomiting, stomach cramps, and diarrhea. Headache is also listed as a potential manifestation of excessive intake.

Severe Outcomes and Risk Considerations

Massive overdosage is associated with potentially life-threatening outcomes, particularly concerning the renal system. These severe manifestations include acute or chronic oxalate nephropathy, the formation of renal oxalate calculi (kidney stones/nephrolithiasis), and potential renal failure. Furthermore, patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency face a documented, unique risk of severe hemolysis and acidosis following high-dose exposure. These renal and hematological risks are explicitly noted in official prescribing information.

Mandated Emergency Action

Official regulatory guidance mandates that immediate medical attention must be sought or the Poison Help line contacted if an overdose is confirmed or strongly suspected. Urgent help is explicitly required if the victim collapses, has a seizure, has trouble breathing, or cannot be awakened. Management is restricted to supportive and symptomatic care, as official labeling states that no specific antidote is known. Hospital monitoring may be required to address the severe outcomes.

Therapeutic Uses of Revitalose

What Revitalose Treats: Main Uses and Benefits

Revitalose is commonly used as a supportive measure in conditions characterized by periods of heightened symptoms related to nutritional status. Its primary therapeutic role is relevant for managing established Vitamin C deficiency (hypovitaminosis C) or supporting efforts to manage low intake in individuals with suboptimal dietary status. This essential micronutrient is relevant for easing general functional strain, providing a supportive therapeutic benefit that helps ease the overall symptom load.

The supplement is applied in clinical scenarios requiring nutritional aid during convalescence—the period of recovery following an illness or intense physical effort. Indications that may be relevant include transient states of general fatigue, asthenia (weariness), and symptoms related to low vitality. By supplying this essential component, the treatment helps address symptom clusters related to overall weakness and supports the body during difficult episodes by easing distress. It is applied in situations where symptoms interfere with daily functioning, assisting with maintaining functional stability and supports general well-being during symptomatic phases.


Quick Fact: Relief for General Weariness

The supplement is commonly used to help with symptoms related to physical discomfort and low vitality. It is often applied during phases when symptoms become more noticeable due to temporary physiological imbalance or increased systemic burden.

Eligibility and Restrictions for Use

Who Can and Cannot Use Revitalose? (Official Eligibility Criteria)

Eligibility for Revitalose, a high-dose Vitamin C and amino acid supplement, is determined by official government regulatory documents based on age, pre-existing health conditions, and sensitivity to the components.

Formal Contraindications (Must Not Use)

Official labeling mandates that Revitalose must not be used by individuals with the following conditions:

  • Hypersensitivity: Known allergy or severe sensitivity to the active ingredients (Sodium Ascorbate, amino acids) or any excipients.
  • Phenylketonuria (PKU): Contraindicated due to the presence of phenylalanine in the formulation.
  • Kidney Stones (Nephrolithiasis): Contraindicated if the Vitamin C daily dose exceeds 1 gram (1000 mg).

Age- and Condition-Based Restrictions

Population Group Eligibility Status (As Per Label) Contextual Restriction
Adults and Adolescents Allowed Typically permitted for ages 15 and over.
Children under 15 Not Recommended Use is generally not advised for this age group.
Pregnancy/Lactation Conditional Use Use is advised only under the strict supervision of a healthcare professional.
Iron Overload Disorders Restricted Requires caution and medical review for conditions like Hemochromatosis/Thalassemia.
G6PD Deficiency Restricted Caution is mandatory when taking doses exceeding 1 gram of Vitamin C.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding interactions with Revitalose is structured around the known pharmacological effects of its active components, primarily Ascorbic Acid (Vitamin C), and not through complex pharmacokinetic pathways like CYP450 or transporter modulation.


Documented Interaction Categories

The most clinically significant constraints documented in regulatory monographs involve interactions that modify drug exposure or pose a risk in specific patient populations.

Interaction Type Interacting Agent / Category Constraint as per Official Document
Absorption Enhancement Iron Preparations Ascorbic Acid enhances the gastrointestinal absorption of non-heme iron.
Pharmacodynamic Risk Oral Anticoagulants High doses of Ascorbic Acid may potentially interfere with the effect of these medicines, necessitating close monitoring of prothrombin time.
Population-Specific Risk Deferoxamine (Chelating Agent) Combination in patients with chronic iron overload may lead to an increased risk of cardiac toxicity.

Official Regulatory Summary

The official profile identifies Iron Salts and Oral Anticoagulants as the primary interacting substance categories. Constraints are procedural, requiring monitoring of coagulation status, or strictly prohibitive in certain disease states, such as the severe risk noted for patients with high iron stores receiving chelation therapy. No specific timing separation requirements are defined in the regulatory interaction section.

Mechanism of Action

How Revitalose Works: Mechanism of Action

️ Modulating Cellular Bioenergetics and Cofactor Supply

The mechanism centers on replenishing vital components that address the body's energy-generating machinery. The inclusion of Magnesium provides a critical cofactor for enzymes involved in the synthesis and utilization of ATP, while Ascorbic Acid (Vitamin C) assists in enzymatic processes that regulate cellular signaling. This action supports the function of enzymes critical for cellular bioenergetics in metabolically active tissues.

Sustaining Tissue Substrate Availability

The formulation supplies a necessary profile of amino acids (including essential Branched-Chain Amino Acids), acting as substrates that directly fuel protein synthesis. This provision increases the availability of substrates for protein synthesis in muscle and other tissues, contributing to the maintenance of their structural and enzymatic components.

️ Providing Systemic Antioxidant Defense

The mechanism includes Ascorbic Acid's activity as a chemical quencher of reactive oxygen species. This antioxidant activity protects sensitive cellular structures, such as mitochondria, from molecular damage, which is required for the sustained function of key metabolic pathways.

Dosage and Administration Information

The administration of Revitalose (C1000 formulation) is standardized around its oral solution form, following explicit instructions detailed in official documents. A single dose consists of two separate units (Ampoule I and Ampoule II, or twin sachets) that must be combined and diluted in a small amount of water immediately before consumption.


Dosing and Preparation Protocol

The medicine is administered solely via the oral route. The usual regimen for adults is one to two doses per day, while adolescents aged 12 years and older typically take one dose daily. Official instructions specify the dose should be taken preferably before the morning and midday meals and must be avoided in the late day or evening. Use is restricted to individuals aged 12 years and older due to the high 1000 mg concentration of Vitamin C.


Duration and Missed Dose Instructions

Treatment duration is typically short-term, and patients are generally advised to seek medical guidance if their condition persists after a few days. If a dose is missed, individuals on a one-dose regimen should take it when remembered. For those on a two-dose schedule, the missed dose should be taken only if it is at least three hours before the next scheduled dose; otherwise, it must be skipped to maintain the proper dosing interval.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Revitalose (Sodium Ascorbate)

This summary provides a descriptive overview of the research and studies that have explored the use of Vitamin C, the active ingredient in Revitalose (Sodium Ascorbate). This information focuses on what research has examined and what findings were reported, without providing clinical advice or making statements about individual outcomes.


Evidence for Use in Addressing General Fatigue and Asthenia (Weariness)

Research into Vitamin C was studied for its potential role in conditions involving periods of heightened symptoms such as general fatigue and feelings of weariness (asthenia). Short-term Randomized Controlled Trials (RCTs) and various observational studies have research examined how people with lower levels of Vitamin C in their system reported their experience when taking the nutrient. The findings describe patterns observed in the studies but findings were mixed when trying to generalize these observations to all participants. Evidence is limited when assessing the effects of the standard oral dose in the general, otherwise healthy population, as much of the available data is associated with the use of high-dose intravenous (IV) administration in medical settings.


Evidence for Use in Correcting Sub-Optimal Vitamin C Status

Research primarily focuses on the role of Vitamin C in the context of low levels or outright sub-optimal nutrient status (hypovitaminosis C). This fundamental research was studied for populations identified as having poor dietary intake, such as smokers or the elderly. Studies monitored the essential role of the nutrient, tracking the measurable correction of low Vitamin C levels in the blood and immune cells. These findings describe patterns related to supplementation and the measurable increase of the nutrient when levels are low. Comparative evidence is lacking to show the distinct differences in absorption efficiency between Sodium Ascorbate and other forms of Vitamin C.


What Remains Uncertain About the Research for Oral Sodium Ascorbate

Certainty remains low in areas where the available studies are limited to high-dose IV administration, making it challenging to draw conclusions about the effects of the standard oral solution for everyday use. There is limited information for long-term outcomes that measure sustained changes in fatigue or quality of life beyond the initial study period, and data for certain groups remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Revitalose (FAQ)


Q: Why is Revitalose sometimes described as an 'anti-fatigue' medicine?

According to official product information, Revitalose is indicated for addressing transient states of fatigue associated with factors like intense physical exertion, overwork, or periods of recovery (convalescence). It is categorized by some agencies as an anti-asthenic medicine, meaning its intended use is to help with feelings of general weariness and lack of energy.


Q: Is Revitalose available over the counter?

Revitalose is typically classified as a non-prescription (OTC) medication in certain regions. It is broadly positioned as a medicine or nutritional support intended for use during temporary periods when the body requires extra micronutrients.


Q: Are there different versions or forms of Revitalose available?

Official information indicates the product is primarily supplied as an oral solution in drinkable ampoules. In some markets, it may also be available in the form of pellets for an oral solution provided in sachets.


Q: Can Revitalose be taken on an empty stomach?

Official instructions recommend taking the medicine with a meal and a large glass of water. The guidance to take it with a meal is specified in the official instructions for use.


Q: Does Revitalose contain any stimulants like caffeine?

The official composition does not list caffeine or classical stimulants. However, regulatory texts advise against taking the medicine late in the day because the Vitamin C component has a documented, slightly stimulant effect.


Q: Can Revitalose affect sleep patterns?

Due to the slightly stimulant effect associated with Vitamin C, official documents state that the medicine should preferably be avoided at the end of the day. The advice to avoid late-day use is included in the official information due to the potential for sleep disturbances.


Q: Is Revitalose suitable for people with diabetes?

Official caution for people with diabetes is necessary because the medicine contains the excipient sorbitol. Additionally, the high content of Vitamin C may potentially modify the response to certain blood and urinary reagents used to test blood sugar levels.


Q: Are there any known issues with taking Revitalose long-term?

Official guidance recommends avoiding prolonged use without professional medical review. Serious risks, such as the formation of kidney stones (renal calcium oxalate calculi), have been documented in association with prolonged, high-dose use of Vitamin C.


Q: Can taking too much Revitalose cause any non-serious side effects?

In cases of very high intake or accidental overdose, certain non-serious adverse effects have been documented. These may include gastrointestinal issues such as stomach pain, diarrhea, and nausea.


Q: Has Revitalose been studied in athletes or for sports performance?

The product is officially indicated for fatigue associated with 'intense physical exertion' and is noted to be used for 'sports recovery', linking its use to the intense physical exertion mentioned in its official indication.


Q: Are there any food types that are known to interact with Revitalose?

Official instructions recommend taking the medicine with a meal. This is due to the Vitamin C component, which is documented to enhance the gastrointestinal absorption of non-heme iron (iron found in plant-based foods).


Q: What are the non-active ingredients in Revitalose?

The non-active ingredients, or excipients, are listed in official documents and include substances such as sorbitol, sodium acetate, glycerol, and preservatives like parahydroxybenzoates. The formulation also contains small quantities of ethanol (alcohol).


Q: Does the evidence for Revitalose focus more on short-term or long-term use?

The maximum recommended duration of treatment for Revitalose is typically limited (e.g., 15 days) in official documents. This indicates that the evidence and official use focuses primarily on short-term intervention for temporary states of fatigue.


Q: How does the listed use for 'temporary fatigue' translate into real-world use?

Official documentation translates the term 'temporary fatigue' into specific, practical contexts. These include fatigue associated with intense physical exertion, the taxing effects of overwork, and the recovery period known as convalescence.


Q: Can Revitalose affect the results of certain medical tests?

Official documents state that the high amount of Vitamin C in the medicine may potentially interfere with the results of certain laboratory tests. This interference is typically with tests that rely on oxidation-reduction reactions, such as specific blood or urinary tests for glucose.


Q: What is the shelf life of Revitalose?

Regulatory texts define the product's lifespan by requiring that the medicine must not be used after the expiration date printed on the packaging. The medicine must also be stored correctly to maintain its integrity until that date.


Q: Can Revitalose cause an allergic reaction?

Official labeling lists a known allergy or severe sensitivity (Hypersensitivity) to any of the ingredients as a formal contraindication. Additionally, certain excipients in the formulation, such as parahydroxybenzoates, are noted as potential causes of allergic reactions.


Q: How is Revitalose classified by regulatory agencies (e.g., drug vs. supplement)?

The product is classified by some agencies as a non-prescription (OTC) drug or medicine intended for temporary support. Internationally, it is often listed under the pharmacotherapeutic classification of Tonics/Anti-asthenics (ATC code A13A), a system used for medicines.

How should Revitalose be stored and disposed of?

How to Store and Dispose of Revitalose?

This section outlines the mandatory storage and disposal rules for Revitalose, as documented in official government regulatory labeling.


Storage Requirements

Revitalose must be stored under specific environmental conditions to maintain its integrity. The official requirement is to keep the product at a temperature not exceeding 25 C. General guidance also recommends protecting the medicine from excessive heat, moisture, or direct sunlight. The product must not be used after the expiration date stated on the packaging.

Child-Safety

For safety, the product must be kept out of the sight and reach of children at all times.

️ Disposal Instructions

Official disposal instructions prohibit discarding the medicine through household waste or down the drain (wastewater). To protect the environment, any unused or expired Revitalose must be returned to a pharmacist for proper, regulated elimination in accordance with current local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Revitalose found in:

A-Z Index: